Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors

By  

Current Drug Targets, Vol. 10, Iss. 11, 2009-11 ,pp. : 1069-1084

Bentham Science Publishers

Access to resources Recommend Favorite

Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 2, 2007-04 ,pp. : 141-149

Bentham Science Publishers

Access to resources Recommend Favorite

HIV Protease Inhibitors - The Next Generation

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 2, 2002-04 ,pp. : 141-162

Bentham Science Publishers

Access to resources Recommend Favorite

Next-generation Metabolomics in the Development of New Antidepressants: Using Albiflorin as an Example

By  

Current Pharmaceutical Design, Vol. 24, Iss. 22, 2018-06 ,pp. : 2530-2540

Bentham Science Publishers

Access to resources Recommend Favorite

Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study

By Rosholm Jens-Ulrik   Andersen Morten   Gram Lars F.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 12, 2001-03 ,pp. : 923-929

Springer Publishing Company

Access to resources Recommend Favorite